Additional information
White Powder
1105067-93-3
ACI-011219
99.5-101.5°C
C33H33FN2O4
540.62
Ambient
2-8°C
Cardiovascular
Pharmaceutical Impurity Standards
(S)-7-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H- pyrrol-1-yl]-5-hydroxyhept-2-enoic acid sodium salt
(S)-7-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H- pyrrol-1-yl]-5-hydroxyhept-2-enoic acid sodium salt
(2E)-2,3-Dehydroxy Atorvastatin





![N-BOC-N-DESHYDROXYETHYL DASATINIB (25 mg) (2-Methyl-2-propanyl 4-[6-({5-[(2-chloro-6-methylphenyl)carbamoyl]-1,3-thiazol-2-yl}amino)-2-methyl-4-pyrimidinyl]-1-piperazinecarboxylate )](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)